Inventor
ORWAR OWE
SE27 patents
⚠️ This page may combine multiple inventors who share the name “ORWAR OWE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELLECTRICON AB
10 patentsUS6388746B1May 14, 2002
Method, apparatus and flow cell for high-sensitivity detection of fluorescent molecules
CELLECTRICON AB177 citations98
US7109034B2Sep 19, 2006
Method for electro-permeabilization of individual cellular and organellar structures and use thereof
CELLECTRICON AB56 citations95
US7018819B2Mar 28, 2006
Method and apparatus for manipulation of cells and cell-like structures focused electric fields in microfludic systems and use thereof
CELLECTRICON AB84 citations95
US6521430B1Feb 18, 2003
Method for electro-permeabilization of individual cellular and organellar structures and use thereof
CELLECTRICON AB59 citations95
US7456012B2Nov 25, 2008
Method and apparatus for spatially confined electroporation
CELLECTRICON AB95 citations91
US6455303B1Sep 24, 2002
Detection of biologically active molecules by use of pre-activated cell-based biosensors in liquid-based separation systems
CELLECTRICON AB38 citations91
US7563614B2Jul 21, 2009
Systems and methods for rapidly changing the solution environment around sensors
CELLECTRICON AB24 citations90
US7470518B2Dec 30, 2008
Systems and method for rapidly changing the solution environment around sensors
CELLECTRICON AB46 citations90
US7390650B2Jun 24, 2008
System and method for obtaining and maintaining high-resistance seals in patch clamp recordings
CELLECTRICON AB8 citations70
US7393680B2Jul 1, 2008
Combined electroporation and microinjection method for the penetration of lipid bilayer membranes
CELLECTRICON AB0 citations51
OBLIQUE THERAPEUTICS AB
5 patentsUS11208384B2Dec 28, 2021
Sulfinylpyridines and their use in the treatment of cancer
OBLIQUE THERAPEUTICS AB2 citations61
US11912765B2Feb 27, 2024
Methods for epitope selection
OBLIQUE THERAPEUTICS AB1 citations58
US11161901B2Nov 2, 2021
Methods for epitope selection
OBLIQUE THERAPEUTICS AB0 citations58
US12590147B2Mar 31, 2026
TRPV1 epitopes and antibodies
OBLIQUE THERAPEUTICS AB0 citations55
US11408883B2Aug 9, 2022
Multi-protease method
OBLIQUE THERAPEUTICS AB1 citations52
PIRAMAL ENTPR LTD
4 patentsUS11234963B2Feb 1, 2022
Pharmaceutical combination for the treatment of cancer
PIRAMAL ENTPR LTD5 citations81
US10555931B2Feb 11, 2020
Pharmaceutical combination for the treatment of cancer
PIRAMAL ENTPR LTD4 citations81
US11925618B2Mar 12, 2024
Pharmaceutical combination for the treatment of cancer
PIRAMAL ENTPR LTD2 citations70
US12383529B2Aug 12, 2025
Pharmaceutical combination for the treatment of cancer
PIRAMAL ENTPR LTD0 citations59
ORWAR OWE
3 patentsUS9126197B2Sep 8, 2015
Pipettes, methods of use, and methods of stimulating an object of interest
ORWAR OWE12 citations79
US8338150B2Dec 25, 2012
Method for combined parallel agent delivery and electroporation for cell structures an use thereof
ORWAR OWE0 citations43
US8268555B2Sep 18, 2012
Method for combined sequential agent delivery and electroporation for cell structures and use thereof
ORWAR OWE0 citations43
FLUICELL AB
3 patentsUS9671366B2Jun 6, 2017
Pipettes, methods of use, and methods of stimulating an object of interest
FLUICELL AB3 citations68
US9658240B2May 23, 2017
Microfluidic device with holding interface, and methods of use
FLUICELL AB4 citations67
US12012578B2Jun 18, 2024
Cell printing utilizing recirculating fluid flows
FLUICELL AB0 citations38